<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The status of growth hormone (GH) secretion together with the effect of GH therapy was studied in six children with <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>One patient had impaired GH secretion, which may, in part, be due to <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The pre-GH-treatment height velocity was 3.8 +/- 0.7 cm/year, but this increased to 6.0 +/- 1.0 cm/year in the first year of treatment and to 4.4 +/- 0.6 cm/year in the second year </plain></SENT>
<SENT sid="3" pm="."><plain>One patient who underwent GH therapy for 4 years showed good response in height velocity </plain></SENT>
<SENT sid="4" pm="."><plain>A considerable variation was observed in response to GH therapy within the treated cases </plain></SENT>
</text></document>